|
CRSP
|
CRISPR Therapeutics AG
|
US
|
NASDAQ
|
|
CRVO
|
CervoMed Inc.
|
US
|
US
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CRXM
|
Taxus Cardium Pharmaceuticals Group Inc
|
US
|
US
|
|
CRYO
|
American CryoStem Corporation
|
US
|
OTC
|
|
CSCI
|
COSCIENS Biopharma Inc.
|
US
|
US
|
|
CSL
|
CSL Limited
|
AU
|
ASX
|
|
CSTL
|
Castle Biosciences, Inc.
|
US
|
NASDAQ
|
|
CTCX
|
Carmell Therapeutics Corporation
|
US
|
US
|
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CTMX
|
CytomX Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CTNM
|
Contineum Therapeutics, Inc. Class A Common Stock
|
US
|
US
|
|
CUE
|
Cue Biopharma, Inc.
|
US
|
NASDAQ
|
|
CUV
|
Clinuvel Pharmaceuticals Limited
|
AU
|
ASX
|
|
CVALF
|
Covalon Tech Ltd
|
US
|
OTC
|
|
CVKD
|
Cadrenal Therapeutics Inc. Common Stock
|
US
|
US
|
|
CVM
|
Cel-Sci Corporation
|
US
|
AMEX
|
|
CWBR
|
CohBar, Inc.
|
US
|
NASDAQ
|
|
CYAD
|
Celyad SA
|
US
|
NASDAQ
|
|
CYAD
|
Celyad SA
|
BE
|
BR
|